New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 31, 2014
10:22 EDTRAREUltragenyx Pharmaceuticals indicated to open $45.00
Ultragenyx Pharmaceuticals (RARE) priced 5.76M shares at $21.00. JPMorgan and Morgan Stanley acted as joint book running managers for the offering.
News For RARE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 30, 2014
09:04 EDTRAREUltragenyx granted EU orphan designation for KRN23
Subscribe for More Information
October 27, 2014
12:22 EDTRAREUltragenyx management to meet with SunTrust
Subscribe for More Information
09:10 EDTRAREUltragenyx granted orphan drug designation for triheptanoin
Subscribe for More Information
October 22, 2014
09:04 EDTRAREUltragenyx triheptanoin granted FDA orphan designation
Subscribe for More Information
October 21, 2014
09:48 EDTRAREShire could target BioMarin, TheStreet's Feuerstein says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use